HAWK Biosystems — Seed (estimated) · ~approximately €760K

HAWK Biosystems' equity crowdfunding round on Capital Cell closed 'con éxito' on 31 March 2023, raising more than 95% of its €800K target, about €760K, at a €12M valuation. The money is for deploying the QF-Pro assay in clinical settings.

Lead not disclosed RoundSeed (estimated) Announced31 Mar 2023 CityDerio SectorHealthtech & Bio · Biotech / Precision oncology diagnostics Source A

Something wrong? Suggest a correction →